8HH Stock Overview
A medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Avanos Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$18.40 |
| 52 Week High | US$22.00 |
| 52 Week Low | US$16.20 |
| Beta | 0.92 |
| 11 Month Change | -9.80% |
| 3 Month Change | -12.38% |
| 1 Year Change | -3.66% |
| 33 Year Change | -32.35% |
| 5 Year Change | -41.03% |
| Change since IPO | -38.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8HH | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.0% | 2.4% | 0.8% |
| 1Y | -3.7% | -5.0% | 9.1% |
Return vs Industry: 8HH exceeded the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: 8HH underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| 8HH volatility | |
|---|---|
| 8HH Average Weekly Movement | 6.9% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8HH's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8HH's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3,771 | Michael Greiner | avanos.com |
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems.
Avanos Medical, Inc. Fundamentals Summary
| 8HH fundamental statistics | |
|---|---|
| Market cap | €766.27m |
| Earnings (TTM) | €20.71m |
| Revenue (TTM) | €650.49m |
37.0x
P/E Ratio1.2x
P/S RatioIs 8HH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8HH income statement (TTM) | |
|---|---|
| Revenue | US$681.50m |
| Cost of Revenue | US$303.20m |
| Gross Profit | US$378.30m |
| Other Expenses | US$356.60m |
| Earnings | US$21.70m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.50 |
| Gross Margin | 55.51% |
| Net Profit Margin | 3.18% |
| Debt/Equity Ratio | 13.2% |
How did 8HH perform over the long term?
See historical performance and comparison